Clinical Trials

15 enrolled

Phase NA Not yet recruiting

Glioma

NCT07465796 2026-03-12

CIPHER

10 enrolled

Glioma, Neoplasms

NCT07464925 2026-03-11

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

30 enrolled

Glioblastoma, Glioma

NCT07455045 2026-03-06

A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

40 enrolled

Glioblastoma, Glioma

NCT07346144 2026-03-04

ADePT

68 enrolled

Glioblastoma

NCT07441707 2026-03-02

A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours

6 enrolled

Low-grade Glioma

NCT07428616 2026-02-24

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

100 enrolled

Brain Neoplasms, Meningioma

NCT07431216 2026-02-24

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

68 enrolled

Phase 3 Not yet recruiting

Glioblastoma

NCT07407803 2026-02-12

Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

177 enrolled

Neurofibroma, Plexiform

NCT07356973 2026-01-26

OPTICAL

147 enrolled

Glioblastoma

NCT07365280 2026-01-26

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

78 enrolled

Glioblastoma

NCT07366892 2026-01-26

IMED-GLOW400

37 enrolled

Glioblastoma, Glioma

NCT07131722 2026-01-23

Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II

25 enrolled

Phase 2/3 Not yet recruiting

Neurofibromatosis 2

NCT07349693 2026-01-20

Cerebraca-02/3

175 enrolled

Glioblastoma

NCT06357377 2026-01-14

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

12 enrolled

Phase NA Not yet recruiting

Choroid Plexus Carcinoma, Glioma, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT07274397 2025-12-10

EARLYBRAINPET

15 enrolled

Brain Neoplasms, Glioblastoma

NCT07164053 2025-11-20

IMED-MYVEO

32 enrolled

Glioma

NCT04373785 2025-10-21

NG101m Adjuvant Therapy in Glioblastoma Patients

52 enrolled

Glioblastoma

NCT07185880 2025-09-22

STAR-GBM

36 enrolled

Glioblastoma

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

60 enrolled

Glioblastoma

NCT07120984 2025-08-13

IMAGLIO

52 enrolled

Glioma

NCT07024394 2025-06-17

Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1

65 enrolled

Neurofibromatosis 1, Neurofibroma, Plexiform

NCT06969352 2025-05-13

VICTORIA

60 enrolled

Glioma

NCT06737146 2024-12-17

Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma

12 enrolled

Glioma

NCT04933422 2024-08-21

CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)

72 enrolled

Glioblastoma

NCT06524063 2024-07-29

Targeted Survivin DC Cell Injection for the Treatment of GBM

9 enrolled

Glioblastoma

NCT06374888 2024-04-19

Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases

28 enrolled

Phase NA Not yet recruiting

Brain Neoplasms

NCT06363201 2024-04-12

Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

40 enrolled

CNSLymphoidSarcoma

Hodgkin Disease, Neoplasms, Neoplasms, Germ Cell and Embryonal, Sarcoma, Central Nervous System Neoplasms

NCT06329570 2024-03-26

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

10 enrolled

Phase 4 Not yet recruiting

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

NCT06047535 2023-09-21

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

62 enrolled

Neuroblastoma

NCT05958472 2023-07-24

Navigating the Clinical Research Process for Glioma

500 enrolled

Glioma

NCT05958485 2023-07-24

A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research

500 enrolled

Glioblastoma

NCT05728125 2023-06-12

Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

500 enrolled

Glioblastoma

NCT05095441 2022-10-12

A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma

51 enrolled

Glioblastoma

NCT05366062 2022-05-13

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

28 enrolled